Acute Effect of Chromatic Environment During Chemotherapy
NCT ID: NCT03873519
Last Updated: 2020-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2018-04-15
2020-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
20 patients will be randomly assigned to one of the four groups, after having signed the Free and Informed Consent Form and agreed to participate in the project, will respond to the evaluation form and will be submitted to physical examination. Patients will be treated per standard of care.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Barriers to Therapeutic Exercise in Breast Cancer Patients Before, During, and After Chemotherapy
NCT06828614
Effects of Bright Light on Co-occurring Cancer-related Symptoms in Breast Cancer Survivors
NCT03304587
Effects of a Group Versus Individual Cognitive Training Program on Chemotherapy-induced Cognitive Impairment (Chemobrain) in Breast Cancer Patients Undergoing Active Treatment
NCT07165912
Cognitive Stimulation and Chemobrain. An Innovative Intervention for Cancer Survivors
NCT05409248
e-CUIDACHEMO: Telerehabilitation During Chemotherapy in Breast Cancer
NCT02350582
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cold North
Group A: Cold color scheme, room facing North
Chromatic Environment
Rooms where chemotherapy sessions are delivered will be modified to show warm/cold color temperature in walls and equipment.
Room Orientation
Room will be facing North or South
Cold South
Group B:Cold color scheme, room facing South
Chromatic Environment
Rooms where chemotherapy sessions are delivered will be modified to show warm/cold color temperature in walls and equipment.
Room Orientation
Room will be facing North or South
Warm North
Group C: Warm color scheme, room facing North
Chromatic Environment
Rooms where chemotherapy sessions are delivered will be modified to show warm/cold color temperature in walls and equipment.
Room Orientation
Room will be facing North or South
Warm South
Group D: Warm color scheme, room facing South
Chromatic Environment
Rooms where chemotherapy sessions are delivered will be modified to show warm/cold color temperature in walls and equipment.
Room Orientation
Room will be facing North or South
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chromatic Environment
Rooms where chemotherapy sessions are delivered will be modified to show warm/cold color temperature in walls and equipment.
Room Orientation
Room will be facing North or South
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with breast cancer that required chemotherapy
* Followed in outpatient clinic
Exclusion Criteria
* Undergoing treatment with antidepressants
18 Years
89 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto Oncológico Balselga
UNKNOWN
Universidad Europea de Madrid
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Margarita Perez
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Margarita Pérez Ruiz, MD, PhD
Role: STUDY_CHAIR
Universidad Europea
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Ruber Internacional
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Gomez-Vela P, Perez-Ruiz M, Hernandez Martin MF, Roman J, Larumbe-Zabala E. Acute effect of orange chromatic environment on perceived health status, pain, and vital signs during chemotherapy treatment. Support Care Cancer. 2020 May;28(5):2321-2329. doi: 10.1007/s00520-019-05064-w. Epub 2019 Sep 3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R-2017/UEM11
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.